tirzepatide beginner dose Dosing for Weight Loss in Units Dosing question : r/tirzepatidecompound

Next-generation compounds like retatrutide may offer additional options as they move through the approval pipeline

Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus in adults (Mounjaro) and chronic weight management (Zepbound) in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

How to choose the right alternative for your situation The sheer number of options can feel overwhelming

Retatrutide is a triple-agonist (GLP-1, GIP, and glucagon receptor) that has shown even more dramatic weight loss results in early trials